Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vav guanine nucleotide exchange factor 1 (VAV1) is a critical intracellular signal transduction protein predominantly expressed in hematopoietic cells, where it acts as a key regulator of T-cell and B-cell receptor signaling. Upon activation by tyrosine phosphorylation, VAV1 functions as a guanine nucleotide exchange factor (GEF) for Rho-family GTPases, primarily Rac1, thereby driving cytoskeletal remodeling, immunological synapse formation, and the activation of downstream transcription factors like NFAT and NF-kB. Because of its central role in lymphocyte activation and cytokine production, dysregulation of VAV1 is heavily implicated in autoimmune and chronic inflammatory diseases, as well as certain hematological malignancies. Historically considered 'undruggable' due to the lack of a classical small-molecule binding pocket, VAV1 has recently emerged as a high-value therapeutic target through the development of targeted protein degradation (TPD) modalities. Novel clinical-stage molecular glue degraders, such as MRT-6160 and EVO570, selectively recruit VAV1 to the cereblon (CRBN) E3 ubiquitin ligase complex, inducing its ubiquitination and subsequent proteasomal degradation to quiet aberrant immune responses.
Targeted protein degradation via molecular glue-mediated recruitment to the cereblon (CRBN) E3 ubiquitin ligase, leading to ubiquitination and proteasomal degradation.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vav guanine nucleotide exchange factor 1 (VAV1).